HOPE Therapeutics and NRx Pharmaceuticals Acquire Interest in Cohen and Associates to Expand Psychiatry Clinics HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. have announced their acquisition of a 49% interest in Cohen and Associates to enhance their interventional psychiatry clinic network.

HOPE Therapeutics and NRx Pharmaceuticals Acquire Interest in Cohen and Associates to Expand Psychiatry Clinics #United_States #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Cohen_and_Associates